These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23238978)

  • 1. The times they are a changin'.
    Yazici Y; Gibofsky A
    Rheumatology (Oxford); 2013 Jan; 52(1):3-4. PubMed ID: 23238978
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing trends for targeted therapies in rheumatoid arthritis among rheumatologists in Southern California, 2008-2010.
    Bagheri S; Wallace DJ
    Arthritis Rheum; 2011 Nov; 63(11):3641. PubMed ID: 21769837
    [No Abstract]   [Full Text] [Related]  

  • 3. Leflunomide in Pakistani patients with rheumatoid arthritis: prospective study in daily rheumatology practice.
    Ahmad NM; Farman S; Saeed MA; Hameed R; Umair M; Ghafoor E
    Int J Rheum Dis; 2011 Feb; 14(1):48-54. PubMed ID: 21303481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving consensus on an algorithm for the treatment of rheumatoid arthritis with methotrexate.
    Ambrose RF; Moreland LW; Kendall LG; Brown S; Koopman WJ; Alarcón GS
    Arthritis Care Res; 1990 Mar; 3(1):53-7. PubMed ID: 2285740
    [No Abstract]   [Full Text] [Related]  

  • 5. Emerging issues in pharmacological management of rheumatoid arthritis: results of a national needs assessment survey identifying practice variations for the development of Canadian Rheumatology Association clinical practice recommendations.
    Bykerk VP; Schieir O; Akhavan P; Hazlewood GS; Cheng CK; Bombardier C
    J Rheumatol; 2012 Aug; 39(8):1555-8. PubMed ID: 21885494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knowledge, attitudes, and clinical practice of rheumatologists in vaccination of the at-risk rheumatology patient population.
    McCarthy EM; Azeez MA; Fitzpatrick FM; Donnelly S
    J Clin Rheumatol; 2012 Aug; 18(5):237-41. PubMed ID: 22832287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintaining and optimising anti-TNF therapy.
    Somerville M
    Musculoskeletal Care; 2007 Dec; 5 Suppl 1():1-17. PubMed ID: 18050263
    [No Abstract]   [Full Text] [Related]  

  • 8. Does cardiovascular risk factor profile influence prescribing of non-steroidal anti-inflammatory drugs in a rheumatoid population?
    Armstrong DJ; Quinn AD; McCausland EM; Wright GD; Finch MB
    Rheumatology (Oxford); 2007 Jul; 46(7):1209-10. PubMed ID: 17522094
    [No Abstract]   [Full Text] [Related]  

  • 9. A qualitative assessment of rheumatoid hand surgery in various regions of the world.
    Kotsis SV; Chung KC
    J Hand Surg Am; 2005 Jul; 30(4):649-57. PubMed ID: 16039353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis?
    Criswell LA; Henke CJ
    J Rheumatol; 1995 May; 22(5):829-35. PubMed ID: 8587068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: a survey.
    Maetzel A; Bombardier C; Strand V; Tugwell P; Wells G
    J Rheumatol; 1998 Dec; 25(12):2331-8. PubMed ID: 9858426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practice variation in the treatment of rheumatoid arthritis among German rheumatologists.
    Zink A; Listing J; Ziemer S; Zeidler H;
    J Rheumatol; 2001 Oct; 28(10):2201-8. PubMed ID: 11669156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Arthrocentesis in rheumatology practice].
    Hartmann H
    Tidsskr Nor Laegeforen; 2000 Mar; 120(7):800-2. PubMed ID: 10806902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All patients with rheumatoid arthritis should receive corticosteroids as part of their management.
    Carette S
    J Rheumatol; 2007 Apr; 34(4):656-60. PubMed ID: 17407224
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of second line drugs for the treatment of rheumatoid arthritis in Edmonton, Alberta. Patterns of prescription and longterm effectiveness.
    Suarez-Almazor ME; Soskolne CL; Saunders LD; Russell AS
    J Rheumatol; 1995 May; 22(5):836-43. PubMed ID: 8587069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-of-life care in rheumatolog: room for improvement.
    Crosby V; Wilcock A
    Rheumatology (Oxford); 2011 Jul; 50(7):1187-8. PubMed ID: 21097447
    [No Abstract]   [Full Text] [Related]  

  • 17. Results from controlled clinical trials: how relevant for clinical practice?
    Kvien TK; Mikkelsen K; Nordvåg BY
    J Rheumatol; 2003 Jun; 30(6):1135-7. PubMed ID: 12784381
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in disease modifying antirheumatic drug prescription in early rheumatoid arthritis are influenced more by hospital setting than patient or disease characteristics.
    Carli C; Ehlin AG; Klareskog L; Lindblad S; Montgomery SM
    Ann Rheum Dis; 2006 Aug; 65(8):1102-5. PubMed ID: 16322085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do French rheumatologists treat early rheumatoid arthritis?
    de Asit N; Le Loët X; Czernichow P; Bertho JM; Delcambre B; Tonnel F; Loyau G; Dapogny C; Trèves R; Valat JP; Tauveron P; Sebert JL; Boumier P
    Rev Rhum Engl Ed; 1996 Mar; 63(3):188-95. PubMed ID: 8731236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modest proposal.
    Lipsky PE
    Nat Clin Pract Rheumatol; 2006 Jul; 2(7):343. PubMed ID: 16932714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.